Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab. (Q54081321)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab. |
scientific article |
Statements
Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab. (English)
Jolien Tol
Jeroen R Dijkstra
Marjolein Klomp
Steven Teerenstra
Martin Dommerholt
M Elisa Vink-Börger
Patricia H van Cleef
J Han van Krieken
Cornelis J A Punt
21 April 2010
46
11
1997-2009